US Patent 11268077 Materials and methods for treatment of hemoglobinopathies
Patent 11268077 was granted and assigned to Vertex Pharmaceuticals on March, 2022 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11268077 Materials and methods for treatment of hemoglobinopathies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
